Skip to Content
Merck
CN
  • A note to the biological activity of benzoxazine derivatives containing the thioxo group.

A note to the biological activity of benzoxazine derivatives containing the thioxo group.

European journal of medicinal chemistry (2010-03-17)
Karel Waisser, Eva Petrlíková, Milan Perina, Vera Klimesová, Jirí Kunes, Karel Palát, Jarmila Kaustová, Hans-Martin Dahse, Ute Möllmann
ABSTRACT

New 3-benzyl-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 3-benzyl-2H-1,3-benzoxazine-2,4(3H)-dithiones were synthesized. The compounds were tested for in vitro antimycobacterial activity against Mycobacterium tuberculosis, Mycobacterium kansasii and Mycobacterium avium. The replacement of the carbonyl group by the thiocarbonyl group increased the antimycobacterial activity. The most active derivatives were more active than isonicotinhydrazide (INH). The cytotoxicity and the antiproliferative activity were studied as well.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Rifampicin, suitable for plant cell culture, BioReagent, ≥95% (HPLC), powder or crystals
Sigma-Aldrich
Rifampicin, ≥95% (HPLC), powder or crystals
Supelco
Isoniazid, analytical standard, ≥99% (TLC)